Breast Cancer, Metastatic
Fulvestrant (Faslodex) is commonly used to
treat advanced or metastatic hormone-related breast cancer in
women who have gone through menopause (postmenopausal).
Fulvestrant (Faslodex) is used in cases that the cancer has progressed and spread to other parts of the body after treated with anti-estrogen medication.
Fulvestrant (Faslodex) is used to help treat HR+/HER2- breast cancer in women without prior treatment or in women with progressed cancer after they have been treated with an anti-estrogen medication.
cell carcinoma of the head and neck (SCCHN).
Fulvestrant (Faslodex) is used to help treat PIK3CA-Mutated, HR+/HER2- advanced breast cancer that has progressed after hormone therapy, or previously treated with Cyclin-Dependent Kinase 4/6 inhibitor (CDKi) + Aromatase Inhibitor (AI).
COMMONLY PURCHASED TOGETHER
REQUEST MORE INFO
Delivering the medication
WHEN YOU NEED IT
even during periods of
shortages in the market.